Yonsei Med J.  2003 Apr;44(2):288-292. 10.3349/ymj.2003.44.2.288.

Anti-Toxoplasma gondii Antibodies in Haemodialysis Patients with Chronic Renal Failure

• Yazar S
• Demirtas F
• Yalcin S
• Yaman O
• Tokgoz B
• Utas C
• Sahin I

• KMID: 1779478
• DOI: http://doi.org/10.3349/ymj.2003.44.2.288

Abstract

This study aimed to determine the prevalence of anti- Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure (CRF). Methods: One hundred and seventy three haemodialysis patients, and 40 healthy controls, were studied for the prevalence of anti-Toxoplasma gondii antibodies by a micro enzyme-linked immunosorbent assay (ELISA). Anti-T. gondii IgG antibodies were detected in 97 (56.06%) haemodialysis patients and 8 (20%) controls with a statistical significance. In addition, anti-T. gondii IgM antibodies were detected in 1.73% of patients, but none of the controls. In conclusion, a high percentage of positivity for Toxoplasma antibodies in patients with CRF undergoing haemodialysis was noticed, thus parasitological surveys of CRF patients should be periodically performed to prevent the possible dissemination of toxoplasmosis through the dialysis procedure.

Keyword

Toxoplasma gondii; haemodialysis; chronic renal failure; ELISA

MeSH Terms

Adolescent
Adult
Aged
Aged, 80 and over
Animals
Antibodies, Protozoan/*blood
Human
Kidney Failure, Chronic/*immunology/therapy
Middle Aged
*Renal Dialysis
Toxoplasma/*immunology